Preventive treatment of nonrheumatic atrial fibrillation: from the efficacy of clinical trials to the effectiveness of clinical practice
Brotons, C.; Moral, I.; Antón, J.J.; Cobos, M.; Cucurull, E.; Gállego, C.; Ibáñez, M.; Pérez, A.; Llussà, J.; Orozco, P.; Ventureira, S.; Samarra, M.; Sanz, J.; Permanyer, G.; López, A.
Atencion Primaria 20(7): 367-371
1997
ISSN/ISBN: 0212-6567 PMID: 9432218 Document Number: 480161
To know the percentage of patients with nonrheumatic atrial fibrillation treated with anticoagulants as an approach to the effectiveness of the prophylactic treatment of stroke. Multicenter observational study. Six primary health centers from Barcelona. 465 patients with the diagnosed of AF were selected during the second semester of 1996. Patients that had suffered a hemorrhagic stroke, or with mitral stenosis, or with a prosthetic valve, or had hyperthyroidism, or receiving anticoagulant therapy were excluded. 299 patients (64%) were finally included for the analysis. 15.8% of the patients were treated with acenocoumarin, and 35.4% were treated with aspirin. The percentage of patients treated improved for high risk patients (higher than 50%). The percentage of patients with nonrheumatic AF treated with acenocoumarin or aspirin is low, and physicians might be reluctant to use them because of bleeding complications, compliance with the treatment, or problems of accessibility.